Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01870115 · ClinicalTrials.gov registry record · Phase 1

Melatonin-Micronutrients for Osteopenia Treatment Study

A Phase 1 study, sponsored by Duquesne University.

Completed
Registry status
Phase 1
Development phase
23
Enrollment target

NCT01870115: Completed Phase 1 study, sponsored by Duquesne University.

NCT01870115 is a Phase 1 study that has completed, run by Duquesne University. The registered enrollment target is 23 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01870115, a Phase 1 study, has completed, sponsored by Duquesne University.

COMPLETED
Registry status
Phase 1
Development phase
23 participants
Enrollment target

Study Summary

The investigators' long-term goal is to employ novel methods to improve bone formation and bone density in women (and men) with osteopenia or osteoporosis while also decreasing signs and symptoms of degenerative joint and disc disease that commonly accompany bone loss as well as improve quality of life (QOL). These conditions generally begin silently as early as the menopause transition and progress to osteopenia and osteoporosis during the post-menopausal years in aging women. The investigators also envision this will be beneficial in aging andropausal men with these conditions. The investigators postulate that melatonin in novel combination with other natural bone-protective agents may act in a "chronosynergy" manner to prevent and correct these perturbations, reducing the risk of bone fractures, and lessening the stiffness and pain associated with bone, joint and cartilage degeneration and improving quality of life (QOL). The objective here, which is the investigators' next step in pursuit of our goal, is to assess the efficacy of an alternative therapy that uses a novel combination of bone-forming agents, melatonin, strontium (citrate)/ vitamin K2 (MK7), and vitamin D3 on bone health in a postmenopausal population. Melatonin is a novel alternative to current treatment(s) because it has multiple bone-protective and sleep-promoting activities within the body, and it is relatively safe so it can be used in an aging population without untoward side effects; strontium and vitamin D3 are shown to enhance bone mineralization and improve post-menopausal osteoporosis. The project goal is to identify if this combination therapy improves bone health and QOL compared to women taking placebo. The investigators' central hypothesis is that combination therapy using melatonin, strontium, vitamin K2, and vitamin D3 will improve bone health and overall QOL in postmenopausal women not taking this regimen by reducing osteoclast activity and increasing osteoblast activity and by imp

Interventions

  • DIETARY_SUPPLEMENT Fiber Pill
  • DIETARY_SUPPLEMENT Melatonin, Strontium citrate, Vitamins D3 and K2

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2013-08
Est. Completion 2017-02-09
Phase Phase 1
Duquesne University

21 total trials

What the finished NCT01870115 record still lists

NCT01870115 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (62% lower).

The record links to 0 conditions, and to 2 interventions - of which Fiber Pill is the first listed.

NCT01870115 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01870115 about?

NCT01870115 is a clinical study titled "Melatonin-Micronutrients for Osteopenia Treatment Study". The investigators' long-term goal is to employ novel methods to improve bone formation and bone density in women (and men) with osteopenia or osteoporosis while also decreasing signs and symptoms of degenerative joint and disc disease that commonly accompany bone loss as well as improve quality of l...

What is the current status of trial NCT01870115?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2013-08. Estimated completion is 2017-02-09.

What interventions are being tested in trial NCT01870115?

The interventions under investigation include: Fiber Pill (DIETARY_SUPPLEMENT), Melatonin, Strontium citrate, Vitamins D3 and K2 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01870115?

This trial is sponsored by Duquesne University, which has 21 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01870115's enrollment target sits among peer trials

23 1596th of 2000 higher than 400 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01870115, the US trial registry maintained by the National Library of Medicine. NCT01870115 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.